Seaview Investment Managers’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,056
Closed -$370K 104
2022
Q2
$370K Sell
7,056
-135,028
-95% -$6.88M 0.17% 66
2022
Q1
$7.36M Sell
142,084
-15,545
-10% -$807K 2.45% 24
2021
Q4
$9.31M Buy
157,629
+23,453
+17% +$1.16M 3.27% 3
2021
Q3
$5.77M Buy
134,176
+6,409
+5% +$284K 2.75% 8
2021
Q2
$5M Buy
+127,767
New +$4.97M 2.56% 19
2021
Q1
Sell
-150
Closed -$6K 132
2020
Q4
$6K Sell
150
-7
-4% -$257 ﹤0.01% 123
2020
Q3
$5K Buy
+157
New +$5.5K ﹤0.01% 106

Other funds holding PFE

Seaview Investment Managers's PFE Position: Q3 2022 in Review

Seaview Investment Managers sold out of Pfizer (PFE) in Q3 2022, closing a stake of 7,056 shares — an estimated $370K sold.

Seaview Investment Managers first reported a position in PFE in Q3 2020 and held it in 7 quarters. The position peaked at $9.31M in Q4 2021. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Seaview Investment Managers reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
  • Seaview Investment Managers sold 7,056 Pfizer shares in Q3 2022, an estimated $370K.
  • Seaview Investment Managers first reported a position in Pfizer in Q3 2020 and held it in 7 quarters.
  • Seaview Investment Managers's Pfizer position peaked at $9.31M in Q4 2021.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Seaview Investment Managers's 13F filing for Q3 2022, filed 10 Nov 2022.